Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon O'Kane

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 29, 2011
Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarringNick L Occleston, Sharon O'Kane, Hugh G Laverty, et al.
Plastic and Reconstructive Surgery|November 3, 2010
Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trialJames Bush, Jonathan A L Duncan, Jeremy S Bond, et al.
Journal of the Peripheral Nervous System : JPNS|November 29, 2007
Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repairSimon Atkins, Alison R Loescher, Fiona M Boissonade, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|July 28, 2010
Remote wound monitoring of chronic ulcersSonja A Weber, Niall Watermann, Jacques Jossinet, et al.
Plastic and Reconstructive Surgery|June 25, 2011
Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trialKaren So, Duncan A McGrouther, James A Bush, et al.
Lancet (London, England)|April 14, 2009
Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studiesMark W J Ferguson, Jonathan Duncan, Jeremy Bond, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|July 29, 2011
Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarringNick L Occleston, Sharon O'Kane, Hugh G Laverty, et al.
Plastic and Reconstructive Surgery|November 3, 2010
Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trialJames Bush, Jonathan A L Duncan, Jeremy S Bond, et al.
Journal of the Peripheral Nervous System : JPNS|November 29, 2007
Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repairSimon Atkins, Alison R Loescher, Fiona M Boissonade, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|July 28, 2010
Remote wound monitoring of chronic ulcersSonja A Weber, Niall Watermann, Jacques Jossinet, et al.
Plastic and Reconstructive Surgery|June 25, 2011
Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trialKaren So, Duncan A McGrouther, James A Bush, et al.
Lancet (London, England)|April 14, 2009
Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studiesMark W J Ferguson, Jonathan Duncan, Jeremy Bond, et al.
Pageof 3